Contact Hours: 1.5

Max CEU Credits: 0.15

Learning Objectives:

Upon completion of the chapter, the reader will be able to:
1. Explain the underlying pathophysiology of vulvovaginal candidiasis, oropharyngeal candidiasis, esophageal candidiasis, and fungal skin infections.
2. Identify symptoms of vulvovaginal candidiasis, oropharyngeal candidiasis, esophageal candidiasis, and fungal skin infections.
3. Identify the desired therapeutic outcomes for patients with uncomplicated and complicated vulvovaginal candidiasis, oropharyngeal candidiasis, esophageal candidiasis, and fungal skin infections.
4. Recommend appropriate lifestyle modifications and pharmacotherapy interventions for patients with vulvovaginal candidiasis, oropharyngeal candidiasis, esophageal candidiasis, and fungal skin infections.
5. Recognize when long-term suppressive therapy is indicated for a patient with vulvovaginal candidiasis.
6. Recognize when topical versus oral treatment is indicated for a patient with oropharyngeal candidiasis, esophageal candidiasis, and fungal skin infections.
7. Educate patients about the disease state, appropriate lifestyle modifications, and medication therapy required for effective treatment of vulvovaginal candidiasis, oropharyngeal candidiasis, esophageal candidiasis, and fungal skin infections.

Faculty:

ACPE No:
014-999-07-095-H04

---

The University of Georgia College of Pharmacy in on probation as an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. Next scheduled review for purposes of restoring accreditation or removing accredited provider status: June 2009